Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16349518 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL8892108 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL12295809 | 0.73 | — | — | |
| SCHEMBL7202507 | 0.73 | GAA (0.40) | ALDH1A1 | |
| SCHEMBL8894389 | 0.69 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL1709016 | 0.69 | — | — | |
| SCHEMBL23697393 | 0.68 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL13406784 | 0.68 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL14068306 | 0.65 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL11688762 | 0.63 | ALDH1A1 (0.47) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210137987-A1 | TARGETING OF MULTIPLE ANTIGENS WITH MULTIPLEX CAR T CELLS IN SOLID AND LIQUID MALIGNANCIES | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-05-13 | — | — | US | disclosed |
| US-5681978-A | Method for the stereocontrolled synthesis of stegobinone and useful borane intermediates | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1997-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210137987-A1 | TARGETING OF MULTIPLE ANTIGENS WITH MULTIPLEX CAR T CELLS IN SOLID AND LIQUID MALIGNANCIES | CD47, CD2, TP53 | ALDH1A1 3705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.